TrialBritish journal of haematology2025

Long-term efficacy and safety of mitapivat in non-transfusion-dependent α- or β-thalassaemia: An open-label phase 2 study.

Kevin H M Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.